Transient E. coli intramammary infections (IMI) are usually associated with rapid onset of clinical signs including mammary gland swelling and abnormal milk with rapid clearance of bacteria from milk. Conversely, reports have described strains of E. coli showing very different clinical trends. Persistent E. coli IMI are associated with mild clinical symptoms that disappear shortly after the onset of infection, possibly flaring-up intermittently during lactation. In the present study, we evaluated a strain of E. coli isolated from a cow with persistent mastitis to determine if the experimental infection model mimics naturally occurring persistent E. coli IMI. Uninfected mammary quarters of 7 Holstein heifers were infused within 10 days of calving with 50 colony-forming units of a persistent E. coli strain. Six of 7 heifers developed mild clinical mastitis with elevated rectal temperatures within 9 to 36 h after infusion. The challenge strain was isolated intermittently in milk from all infected mammary quarters during the first two weeks after infusion and 3 animals continued to shed E. coli periodically during the sampling period. One animal shed E. coli intermittently in milk for 172 d after challenge and developed clinical mastitis four times during this period. The isolated strain had an identical pulsed-field gel electrophoresis profile as the E. coli strain used to infuse mammary glands. The experimental IMI model described here mimics very closely naturally occurring persistent E. coli IMI, thus providing an excellent in vivo model to better understand pathogenesis and to facilitate development of control strategies for this important mastitis pathogen.
Current mastitis control programs devised in the 1960’s are based on hygiene including teat disinfection, antibiotic therapy, and culling of persistently infected cows. Acceptance and application of these measures has led to considerable progress in controlling contagious mastitis pathogens. However, these same procedures are less effective against environmental pathogens such as E. coli because of the low susceptibility of E. coli to common mastitis treatments [
Transient E. coli mastitis is associated with rapid onset of clinical symptoms including mammary gland swelling and abnormal milk with rapid elimination of bacteria from milk. In some cases, severe systemic involvement occurs and when not properly diagnosed and treated, it could result in the death of the affected animal. Reports have also described strains of E. coli showing very different clinical trends. For example, there are reports on E. coli strains associated with persistent IMI which often times start with mild clinical symptoms that disappear soon after the onset of infection only to flare-up again during lactation, usually resulting in mild clinical mastitis [3-5]. Escherichia coli associated with persistent mastitis have been isolated in milk for long periods in spite of a high number of somatic cells in milk [
The E. coli strain ECC-1470 [3,7] isolated originally in milk from of a cow with persistent mastitis was used. The challenge inoculum was a frozen stock that was thawed, grown in Luria Bertani broth (Becton Dickinson Company, Sparks, MD, USA) overnight at 37˚C and diluted serially to a concentration of approximately 50 colony-forming units (CFU) in 5 ml of sterile phosphate buffered saline (PBS, pH 7.4).
Seven healthy Holstein heifers free of mastitis and any other infectious disease were used. For the experimental infection protocol, animals were grouped together, milked last and included in normal herd practices.
One uninfected mammary gland of 7 Holstein heifers was infused with E. coli strain ECC-1470. Following disinfection of the teat end with ethanol, a bacterial suspension with a concentration of approximately 50 CFU in 5 ml of sterile PBS was infused into the teat cistern using sterile disposable syringes fitted with sterile disposable teat canulas. Heifers were challenged within 10 days of calving; one heifer was challenged 2 d before calving, one at calving, two at 1 d after calving, one at 2 d after calving, one at 6 d after calving, and one at 8 d after calving. Post-calving infusions with the bacterial challenge suspension were administered within 20 min after milking. The protocol used for experimental infection of heifers was reviewed and approved by The University of Tennessee Institutional Animal Care and Use Committee.
Heifers and mammary glands were monitored extensively during the first week after experimental challenge. Animal observations including appetite, restlessness, mobility, and responsiveness were evaluated. Rectal temperatures were taken using a digital thermometer and recorded. Milk samples for microbiological evaluation and enumeration of somatic cell counts (SCC) were obtained twice daily for one week after challenge and twice weekly thereafter for a minimum of 56 days, or longer if E. coli was still isolated from milk. Pulsed-field gel electrophoresis (PFGE) patterns of E. coli isolated at intervals following challenge were evaluated. Milk and mammary condition were evaluated using the following scoring system: Milk Score: 1 = normal milk, 2 = flakes, 3 = small slugs, 4 = large slugs/clots, 5 = stringy/watery. Mammary Gland Score: 1 = normal; the udder was pliable when totally milked out. Heat, pain, redness, and/or swelling were not detectable; the animal exhibited no signs of discomfort; 2 = slight swelling; the udder was less pliable with some firmness as if not totally milked out. Additional milking or stripping did not return the gland to normal. Redness, heat and pain were generally not detectable and animals generally did not exhibit signs of discomfort; 3 = moderate swelling; the udder was definitely firm, reddened and warm to the touch. The udder did not return to normal size when milked out. The animal generally exhibited signs of discomfort (irritable, performs a stepping motion with feet and/or kicks) during prepping and milking procedures; 4 = severe swelling; the udder was very hard, red, hot and noticeably larger than other mammary quarters before milking with little or no change in size following milking. The animal was extremely uncomfortable and very irritable.
Milk samples were collected aseptically from challenged mammary glands for bacteriological evaluation and SCC every 3 h during the first 12 h (CH + 12 h), every 6 h from CH + 12 h to CH + 24 h, and every 12 h until CH + 168 h. At each sampling point, teats were washed thoroughly, dried with individual disposable paper towels, and teat ends were cleaned with swabs containing 70% isopropyl alcohol. Milk samples for microbiological analysis were collected into sterile screw-cap tubes and keep at –20˚C until evaluation. Samples for SCC were collected into snap cap 50 ml tubes containing milk preservative pills and kept at 4˚C until processing. Bacteriological evaluation of milk samples was conducted at the Tennessee Milk Quality Laboratory. Samples (10 and 100 ml) were plated onto blood and MacConkey agar, and one ml was placed on a Petrifilm Coliform Count Plate (3M Company, St. Paul, MN, USA). Somatic cell counts were conducted at the Tennessee Dairy Herd Improvement Association laboratory following standard procedures.
Pulsed-field gel electrophoresis (PFGE) patterns of E. coli isolated at intervals following challenge were analyzed as described [
Six of 7 heifers became infected following intramammary challenge. These heifers developed mild cases of clinical mastitis characterized by abnormal milk for a few days after challenge and slight to moderate swelling of the challenged mammary gland for up to a week after challenge. Initial clinical manifestations as evidenced by the presence of flakes and small slugs in milk and slight swelling and redness of the infused mammary gland were noticed at 18 h after inoculation reaching a peak at approximately CH + 72 h. At this inspection point, inoculated mammary glands showed swelling, firmness, redness, and were warm to the touch. Milk from inoculated mammary glands had moderate to large slugs. After 72 h, clinical symptoms declined, becoming moderate with slight swelling of the infused mammary gland and presence of small slugs in milk. Elevated rectal temperatures were detected approximately at CH + 9 h, reaching a peak approximately at CH + 12 h and declining to normal values 96 h after challenge (
Escherichia coli were isolated in milk from all infected mammary glands frequently during the first week after challenge (
One animal shed E. coli in milk intermittently for 172 d after challenge (
In milk from all challenged mammary glands, SCC increased very rapidly during the first 9 h after inoculation reaching values of ~7.0 log10 at CH + 12 h. These SCC values were maintained throughout the entire sampling period and appeared to be unaffected by fluctuations in CFU/ml of E. coli in milk (Figures 2 and 3).
Several studies have shown the increasing importance of E. coli IMI and indicated that these IMI have become a major problem in many well-managed dairy farms since
they cause significant milk loss and frequent culling and/or death of infected cows [9-12].
A study from Wisconsin reported an increased prevalence of E. coli from 17.7% to 24.9% of the total mastitis pathogens isolated [
In the United Kingdom, E. coli was also shown to be the most important pathogen in well-managed dairies [
Typically, E. coli mastitis is associated with acute onset of clinical signs including mammary gland swelling and abnormal milk with rapid elimination of bacteria from milk. In some cases, severe systemic involvement occurs and when not properly diagnosed and treated, it could result in death of the animal. However, an increasing number of reports have described strains of E. coli showing chronic and persistent IMI [3-5]. These persistent IMI usually start with mild clinical symptoms that disappear soon after the onset of infection only to flareup again during lactation, generally resulting in mild clinical mastitis.
In this investigation using a strain of E. coli isolated from a cow with persistent mastitis, we were able to induce IMI with positive isolation of the challenge strain of E. coli in milk and clinical manifestations resembling persistent mastitis from which the strain was isolated initially [3,4]. Results from this investigation also showed that the strain used for infusing mammary glands was repeatedly isolated during the sampling period and into lactation. One animal shed E. coli in milk intermittently for 172 d after challenge (Figures 3 and 4) and developed clinical mastitis four times (
It is well accepted that clinical manifestations of any infectious disease result from the interplay between host defenses and virulence of the infectious agent. Results of the present study showed that experimental infection of heifer mammary glands during the periparturient period with a strain of E. coli isolated originally from a cow with persistent IMI caused mild clinical mastitis initially. In some animals, the challenge strain persisted for long periods of time in spite of a high number of somatic cells in milk similar to what was observed in cows with naturally occurring persistent E. coli mastitis [3,4]. Thus, based on experimental and natural infection data, E. coli strains associated with persistent IMI appear to behave quite differently from strains of E. coli that cause transient acute mastitis. Acute E. coli mastitis is usually associated with rapid onset of clinical signs of mastitis including mammary gland swelling and abnormal milk with rapid clearance of bacteria from milk. Persistent E. coli mastitis, on the other hand, results in mild clinical mastitis and the strain persists in milk for very long periods in spite of a high number of somatic cells in milk. Previous results showed that persistent E. coli strains possess enhanced adherence and internalization capabilities as compared with acute E. coli strains [3,4]. Furthermore, work from our lab and other laboratories demonstrated that persistent strains of E. coli were capable of circumventing intracellular bactericidal mechanisms such as endosome acidification and endosomelysosome fusion thus allowing intracellular persistence of these strains [6,7]. Such avoidance mechanisms are very likely the cellular basis to explain persistent IMI caused by these E. coli strains. From a practical standpoint, these results indicate that E. coli strains with these characteristics are able to persist for long periods in the affected mammary glands thus creating reservoirs of persistent E. coli strains in the herd. Such reservoirs are very difficult to control since these strains are resistant to host surveillance systems, and specialized in gaining access to microenvironments where host defenses or antimicrobials present in milk are not effective.
In conclusion, we have developed an experimental E. coli IMI model that mimics clinical symptoms observed in natural persistent E. coli mastitis. Strains of E. coli associated with persistent IMI appear to behave quite differently from strains of E. coli causing transient mastitis. The in vivo experimental infection model developed in the present study could be a useful and valuable tool to better understand pathogenesis and to facilitate development of control strategies for this important mastitis pathogen.
This research was funded by the Tennessee Agricultural Experiment Station, The University of Tennessee College of Veterinary Medicine Center of Excellence Research Program in Livestock Diseases and Human Health, and Epitopix, LLC, Wilmar, MN.